Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Flare Capital Partners is a venture capital firm based in Boston, Massachusetts, specializing in healthcare technology investments. Founded by Bill Geary, the firm has been active in the healthcare investment space for nearly three decades, establishing a strong presence in the industry. Flare Capital manages approximately $1 billion in assets under management (AUM) across multiple funds, including Fund III, which raised $350 million in 2022.
The firm has built a diverse portfolio of 77 companies, focusing on improving healthcare outcomes and reducing costs through innovative technology solutions. Flare Capital operates primarily in the United States and has a team of 65 professionals, including 16 partners, who bring deep healthcare domain expertise and access to the Boston healthcare ecosystem.
Flare Capital Partners invests in healthcare technology across various stages, including seed, Series A, and Series B. The firm targets sectors such as biotech, digital health, healthcare SaaS, and clinical information systems. Their investment strategy emphasizes co-creation with a strategic network of limited partners, which includes payers, providers, and health systems. This approach allows Flare Capital to partner with entrepreneurs who are committed to transforming the healthcare business model.
The firm seeks to address significant market opportunities and values founder-market fit, aiming to support companies throughout their entire journey—from initial team building and product development to scaling and exit strategies. Check sizes typically range from $2 million to $15 million, reflecting their commitment to providing substantial support to promising healthcare startups.
Flare Capital Partners boasts a diverse portfolio of 77 healthcare technology companies. Notable companies in their portfolio include:
Bill Geary: Co-Founder and General Partner, has extensive experience in healthcare investments and has been instrumental in shaping the firm's strategy.
Michael Greeley: Co-Founder and General Partner, brings a wealth of knowledge in venture capital and healthcare technology.
Adam Bruce: Partner and Chief Financial Officer, oversees financial operations and fund management.
Ian Chiang: Partner, focuses on sourcing and evaluating investment opportunities.
Parth Desai: Partner, specializes in healthcare technology investments.
Dan Gebremedhin, MD: Partner, brings clinical expertise to the investment process.
Victor Lanio: Partner, focuses on strategic partnerships and business development.
Margaret Malone: Partner, involved in portfolio management and operational support.
Tara Sullivan: Principal, supports investment analysis and due diligence.
Amanda DiTrolio: Vice President of Marketing and Platform, manages marketing strategies and platform initiatives.
Caroline Glen: Vice President of Investor Relations, oversees communications with investors.
Kendall Cook: Manager of Events and Community, coordinates community engagement and events.
Jonathon George: Senior Associate, assists in investment research and analysis.
Uma Veerappan: Vice President, involved in investment strategy and portfolio management.
To pitch Flare Capital Partners, startups should use the contact form available at flarecapital.com/contact or email flare@flarecapital.com. It is advisable to include a concise executive summary, details about the team, and an overview of the product or service. Response times may vary, so founders should be prepared for follow-up discussions.
Flare Capital Partners runs the Flare Scholar Program, designed to cultivate the next generation of healthcare technology leaders. This program aims to provide mentorship and resources to emerging entrepreneurs in the healthcare space. Specific details regarding eligibility and application processes have not been disclosed.
On December 1, 2025, Flare Capital Partners made its latest investment, continuing its active engagement in the healthcare technology sector. Over the past 12 months, the firm has completed 10 investments, reflecting its commitment to supporting innovative healthcare solutions.
Notable exits from their portfolio include the acquisition of Aetion in 2025, which underscores the firm's successful investment strategy and focus on high-impact healthcare technology companies.
Q?
What are Flare Capital Partners' investment criteria?
Flare Capital focuses on healthcare technology investments across seed to Series B stages, emphasizing co-creation with health system LPs and significant market opportunities.
Q?
How can startups apply or pitch to Flare Capital Partners?
Startups can pitch Flare Capital through their contact page at flarecapital.com/contact or via email at flare@flarecapital.com.
Q?
What makes Flare Capital Partners different from other VCs?
The firm employs a co-creation model with strategic LPs, allowing them to partner closely with health systems and leverage their expertise to enhance startup success.
Q?
What is the geographic scope of Flare Capital Partners?
Flare Capital primarily invests in companies based in the United States.
Q?
What is the typical check size for investments?
Flare Capital typically invests between $2 million and $15 million in their portfolio companies.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.